Beers Criteria Explained: A Guide to Potentially Inappropriate Drugs for Seniors

Imagine a routine check-up where your doctor prescribes a common sleep aid or a standard painkiller. For a 30-year-old, these are harmless conveniences. For an 80-year-old, they could be the trigger for a dangerous fall, a hospital visit, or even cognitive decline. This isn't hypothetical fear-mongering; it is a documented reality of how aging bodies process chemicals differently than younger ones.

This is exactly why the Beers Criteria exist. They are not just a list of "bad drugs" but a vital roadmap for clinicians navigating the complex world of prescribing for older adults. If you are a caregiver, a patient over 65, or a healthcare professional, understanding this framework is one of the most effective ways to prevent adverse drug events (ADEs) and maintain independence in later life.

What Are the Beers Criteria?

The American Geriatrics Society (AGS) Beers Criteria® for Potentially Inappropriate Medication (PIM) Use in Older Adults is a comprehensive, evidence-based guideline designed to identify medications that pose greater risks than benefits for individuals aged 65 and older. Originally developed by Dr. Mark Beers and his colleagues in 1991, the criteria address a fundamental biological shift: as we age, our pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes drugs) and pharmacodynamics (how drugs affect the body) change significantly.

Think of it like this: a liver or kidney that worked efficiently at age 40 might process toxins 50% slower at age 75. A dose that was safe before can become toxic later. The Beers Criteria were created to flag these mismatches. Since 2011, the American Geriatrics Society has taken over the responsibility of updating these guidelines, ensuring they reflect the latest scientific evidence. The most recent edition, published in 2023, reviewed over 1,500 scientific articles to refine its recommendations.

It is crucial to understand what the Beers Criteria are *not*. They are not a punitive checklist used to judge doctors harshly, nor are they absolute rules that dictate every prescription. As Todd Semla, MS, PharmD, BCGP, FCCP, AGSF, co-chair of the 2023 expert panel, emphasized, the criteria should never "solely dictate how medications are prescribed or be used to justify restricting health coverage." Instead, they serve as a warning light-a tool to prompt deeper conversation between patients, caregivers, and providers.

The Five Pillars of the 2023 Update

The 2023 update of the Beers Criteria is structured into five distinct sections, each targeting a specific risk area. Understanding these categories helps demystify why certain medications are flagged.

1. Medications to Avoid Regardless of Condition: These are drugs that offer little benefit to most older adults while carrying high risks. Examples include certain antihistamines (like diphenhydramine/Benadryl) which can cause confusion and urinary retention, and skeletal muscle relaxants (like carisoprodol) which increase fall risk.
2. Medications to Avoid with Specific Diseases: Some drugs exacerbate existing conditions. For instance, nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen should generally be avoided in patients with heart failure or chronic kidney disease because they can worsen fluid retention and kidney function.
3. Medications to Use with Caution: These drugs may be necessary but require careful monitoring. Opioids, for example, can manage severe pain but carry a high risk of constipation, sedation, and falls. The criteria specify lower starting doses and shorter durations.
4. Medications to Avoid with Renal Impairment: Kidney function declines naturally with age. The criteria list specific drugs that must be dose-adjusted or avoided entirely based on estimated glomerular filtration rate (eGFR). This includes certain antibiotics and diabetes medications like metformin if kidney function drops below specific thresholds.
5. Clinically Significant Drug-Drug Interactions: Older adults often take multiple medications (polypharmacy). The criteria highlight dangerous combinations, such as mixing warfarin with certain antibiotics, which can spike bleeding risks.

In total, the 2023 update incorporates 131 specific medication criteria. Of these, 89 apply to all older adults, 22 relate to specific disease states, and 20 address renal impairment considerations. This granular approach allows clinicians to tailor care rather than applying a blanket ban on entire drug classes.

Why Does This Matter? The Risk of Polypharmacy

Polypharmacy-the use of multiple medications simultaneously-is incredibly common in geriatric care. Approximately 40% of older adults take five or more prescription drugs. While some of this is necessary for managing chronic conditions like hypertension, diabetes, and arthritis, it creates a web of potential interactions.

Research by Page et al. (2012) indicates that about 20% of older adults experience potentially inappropriate prescribing according to Beers Criteria metrics. The consequences are stark. Studies show that PIMs defined by the Beers criteria are associated with increased hospital admissions, functional decline, and higher mortality rates. A study published in PMC (2014) found that when applying the Beers Criteria to Alternate Level of Care (ALC) patients, 45.7% were receiving at least one potentially inappropriate medication. This highlights a massive gap in current care practices.

Adverse drug events (ADEs) are not just statistical anomalies; they are leading causes of emergency room visits among seniors. Falls resulting from sedative-hypnotics, gastrointestinal bleeding from NSAIDs, and confusion from anticholinergics are preventable tragedies. The Beers Criteria provide the evidence base to intervene before these events occur.

Implementation Challenges: Beyond the Checklist

While the Beers Criteria are widely adopted, their implementation is not without friction. The Centers for Medicare & Medicaid Services (CMS) incorporated Beers Criteria metrics into nursing home quality reporting since 2012. This drove widespread adoption but also generated controversy. Some critics argue that regulatory bodies have turned clinical guidance into rigid compliance checkboxes, potentially limiting physician autonomy.

Christine Holman, PharmD, BCGP, BCPS, a clinical pharmacy specialist in geriatrics, characterizes the criteria as a "warning light" rather than absolute rules. She emphasizes that "medication decisions should be individualized and based on shared decision making between the healthcare team, patients, and caregivers." This distinction is vital. A drug listed in the Beers Criteria might still be appropriate for a specific patient with limited life expectancy who values symptom control over longevity, or for someone who has failed all other treatments.

The American Geriatrics Society explicitly warns against punitive application. They note that "quality measures must be clearly defined, easily applied, and measured with limited information and, thus, although useful, cannot perfectly distinguish appropriate from inappropriate care." Successful implementation requires integrating these criteria into electronic health record (EHR) systems with clinical decision support, allowing doctors to see alerts in real-time while retaining the ability to override them with justified clinical reasoning.

How to Use the Beers Criteria in Practice

For patients and caregivers, the Beers Criteria are accessible resources, not just medical jargon. The AGS provides layperson versions at healthinaging.org to facilitate discussions during appointments. Here is a practical approach to leveraging these guidelines:

• Conduct a Comprehensive Medication Review: Bring all prescriptions, over-the-counter drugs, vitamins, and supplements to your doctor. Many OTC drugs, like sleep aids and allergy medications, contain ingredients flagged by the Beers Criteria.
• Ask About Deprescribing: Deprescribing is the planned and supervised tapering or discontinuation of medications that may be causing harm or are no longer beneficial. Ask your provider: "Is this medication still necessary given my current health status?"
• Monitor for Side Effects: If you start a new medication, watch for changes in balance, mental clarity, or digestion. Report these immediately. Early detection of adverse effects can prevent hospitalization.
• Utilize Technology: Clinicians can use the AGS mobile app or pocket reference card available through GeriatricsCareOnline.org. Patients can ask if their doctor uses these tools during reviews.

The AGS also promotes the "5 Steps to Medication Review" framework for patients with multimorbidity. This structured approach ensures that every medication is evaluated for effectiveness, safety, and necessity, aligning closely with the spirit of the Beers Criteria.

Future Directions: Personalization and Precision

As medical science advances, the Beers Criteria will likely evolve toward greater personalization. Future updates are expected to integrate pharmacogenomics data-genetic information that predicts how an individual will respond to specific drugs. This would move beyond age-based generalizations to truly personalized medicine.

Additionally, enhanced electronic health record decision support aims to reduce alert fatigue by providing smarter, context-aware warnings. However, the AGS cautions against over-reliance on any single tool. The Beers Criteria remain one of the essential tools for guiding safer medication use, but they work best when combined with clinical judgment, patient preferences, and regular monitoring.

The long-term viability of the Beers Criteria appears strong, supported by major healthcare organizations and federal quality measurement programs. By continuing to refine these guidelines, the medical community can better protect older adults from the hidden dangers of inappropriate prescribing, ensuring that medication serves as a bridge to health, not a barrier to well-being.